Partnership Opportunities
Partner with the Only Industry-Dedicated Kinase Inhibitor Meeting
to Maximize your Influence
The 3rd Kinase Targeted Drug Discovery Summit was a transformative forum bringing together 80+ kinase experts from the pharmaceutical, biotechnology, and academic sectors. From target identification and lead optimization to assay development, our attendees formed an engaged audience dedicated to preclinical kinase success.
Our industry’s decision-makers needed your latest platforms, tools, and technologies to maximize their discovery capabilities to achieve the next generation of kinase therapies.
Who Attended?
Why Partner?
Don’t miss your chance to:
Enable highly sensitive assays that can screen against a comprehensive set of kinases
Display advanced phospho-proteomic profiling platforms that can identify critical phosphorylation sites
Spotlight computational drug design tools that can enhance predictive models of complex kinase interactions
Present ground-breaking cryo-EM technologies that can deliver high-resolution structures of transient domains
Address Critical Industry Needs
Our Kinase Drug Developers & Researchers Need Your Help With:
Highly sensitive kinase assays
Advanced phospho-proteomic profiling platforms
Computational and AI drug design tools
Ground-breaking cryo-EM technologies